University of Massachusetts Worcester, Site #152 — Worcester, Massachusetts

University of Massachusetts Worcester, Site #152 is a clinical research site located in Worcester, Massachusetts, United States 01655.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

University of Massachusetts Worcester, Site #152 has participated in 2 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Chronic Myeloid Leukemia.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Massachusetts Worcester, Site #152?

University of Massachusetts Worcester, Site #152 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Massachusetts Worcester, Site #152 conducted?

University of Massachusetts Worcester, Site #152 has 2 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Chronic Myeloid Leukemia.

Is University of Massachusetts Worcester, Site #152 accredited by Crixeo Health?

University of Massachusetts Worcester, Site #152 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Massachusetts Worcester, Site #152?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.